Digitalni repozitorij raziskovalnih organizacij Slovenije

Izpis gradiva
A+ | A- | SLO | ENG

Naslov:Klinični primer bolnika z razsejanim ploščatoceličnim karcinomom požiralnika
Avtorji:Boc, Marko (Avtor)
Mesti, Tanja (Avtor)
Reberšek, Martina (Avtor)
Jezik:Slovenski jezik
Tipologija:1.09 - Objavljeni strokovni prispevek na konferenci
Organizacija:Logo OI - Onkološki inštitut Ljubljana
Ključne besede:rak požiralnika, ploščatocelični rak, radiokemoterapija, rak prebavil
Leto izida:2014
UDK:616.3-006
ISSN pri članku:1408-1741
OceCobissID:1807227 Povezava se odpre v novem oknu
URN:URN:NBN:SI:doc-BLXFYRI4
COBISS_ID:1809787 Povezava se odpre v novem oknu
Število ogledov:1318
Število prenosov:355
Datoteke:.pdf PDF - Predstavitvena datoteka, prenos (350,35 KB)
 
Nadgradivo:Šola: tumorji prebavil II, Ljubljana, 15. 11. 2013
Onkološki inštitut
 
Metapodatki:XML RDF-CHPDL DC-XML DC-RDF
Avtorske pravice:by Authors
:
  
Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.


Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.
Začetek licenciranja:31.08.2018

Sekundarni jezik

Jezik:Angleški jezik
Naslov:[A clinical case of a patient with metastatic squamous cells carcinoma of the oesophagus]
Povzetek:The incidence of oesophageal cancer has not changed in the last years, neither in the world nor in Slovenia. According to the 2012 Cancer Registry of Slovenia, a total of 87 patients were diagnosed with oesophageal cancer in 2009, of which 74 were males and 13 were females. The most common histological type was squamous cell carcinoma; in 2009, there were 60 such patients, while adenocarcinoma, which is the second most common type, was found in 19 patients. Patients with oesophageal cancer have a poor prognosis. A half of these patients have advanced disease already at diagnosis. Median survival with advanced disease is eight to ten months, while 5-year survival is merely 5-17%. When the disease is operable, patients are treated surgically, and if the disease is limited locoregionally, the patients are treated with pre-operative chemoradiotherapy and surgery. However, despite such primary treatment, the disease recurs in approximately 65% of patients in the first five years, either in a form of metastases or as a local recurrence (2, 3, 4, 5, 6). In this article, we present a patient with squamous cell carcinoma of the middle third of the oesophagus which has started to spread to the upper and lower thirds six months after primary treatment and effective first-line systemic treatment.

Arhiv

niGradiv

Nazaj